A man from Philadelphia sues Johnson & Johnson, claiming that pharmaceutical drug giant Invokana's diabetes drug has damaged his kidneys. Invokana is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
It was almost two years after it was put on the market for the US Food and Drug Administration to determine that Invokana was producing "too much acid in the blood" and "causing serious infections. urinary tract ".
A series of side effects reported, but the drug still remains on the market:
On December 4, 2015, the FDA forced Johnson & Johnson and other manufacturers of SGLT2 inhibitors to warn consumers through labeling that the drugs could cause ketoacidosis, a serious condition that can put diabetics in the dark. coma and even cause their death.
The drug Invokana has also been linked to other complications. In 2015, it was reported that Invokana may increase the risk of developing kidney problems, including "kidney failure, dehydration and water imbalances, kidney stones, urinary tract infections and abnormal weight loss". .
Many patients complain about the side effects of the drug:
Portnoff, a type 2 diabetic, claims to have noticed the adverse effects of Invokana just a few months after taking it as part of his treatment. He accuses Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, of having put the drug on the market without conducting sufficient studies to ensure its safety for patients.
Not only does Portnoff accuse Janssen of not alerting consumers to the risk, he also accuses the pharmaceutical giant of hiding information on the risk of diabetic ketoacidosis and other undesirable effects of the drug.
Portnoff is just one among many patients complaining about the unwanted effects of Invokana. An Illinois named William C. Counts, also sued Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanaba Pharma Corp., alleging that Invokana had damaged his kidneys.